Kymab Limited
Cambridge, United Kingdom
Purpose
to generate an effective human neutralising antibody against the toxin of Bordetella pertussis, the causative agent of whooping cough
Division
Global Health
Date
December 2015
Region Served
GLOBAL
Committed amount
$1,499,332
Grant topic
Pneumonia & Pandemic Preparedness
Duration (months)
51
Grantee location
Cambridge, United Kingdom
Related work
More about our financials
Our story
Learn about the origins of the foundation and the values that drive our work.
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.